Aims and Scope
Pharmacotherapy in Psychiatry and Neurology is an international, peer-reviewed journal dedicated to advancing research in psychiatry, neurology, clinical neuroscience, and pharmacotherapy. While the journal places particular emphasis on pharmacological treatments and related therapeutic approaches, it also welcomes high-quality research addressing the broader biological, clinical, and translational aspects of psychiatric and neurological disorders. The journal provides a platform for the dissemination of research that improves the understanding, prevention, diagnosis, and treatment of mental, neurological, and neurodevelopmental disorders.
The journal welcomes original research articles, systematic reviews and meta-analyses, narrative reviews, editorials, and correspondence. Submissions should contribute to scientific knowledge with clear clinical, translational, or public health relevance.
The scope of the journal includes, but is not limited to:
- Clinical psychiatry and neurology
- Psychopharmacology and neuropharmacology
- Pharmacotherapy of psychiatric and neurological disorders across the lifespan
- Clinical trials of pharmacological, biological, and non-pharmacological interventions
- Precision medicine and personalized treatment
- Pharmacogenetics and pharmacogenomics
- Therapeutic drug monitoring and clinical pharmacokinetics
- Drug safety, tolerability, and pharmacovigilance
- Mechanisms of action of psychiatric and neurological treatments
- Translational and clinical neuroscience
- Neurobiology and pathophysiology of psychiatric and neurological disorders
- Biomarkers, neuroimaging, electrophysiology, and digital biomarkers
- Cognitive, affective, and behavioral neuroscience
- Drug repurposing and innovative therapeutic strategies
- Combination therapies, augmentation approaches, and neuromodulation
- Evidence-based medicine, clinical guidelines, and treatment algorithms
- Real-world evidence, pharmacoepidemiology, and health services research
- Digital psychiatry, digital neurology, and artificial intelligence in clinical practice
- Prevention, early intervention, and public mental health
- Ethical, regulatory, and public health aspects of psychiatric and neurological care
The journal encourages interdisciplinary research bridging psychiatry, neurology, neuroscience, pharmacology, psychology, genetics, immunology, endocrinology, epidemiology, and data science. Clinical, translational, epidemiological, computational, and experimental studies are all welcome.
Priority is given to manuscripts demonstrating methodological rigor, scientific novelty, and meaningful implications for clinical practice or future research. The journal aims to serve clinicians, researchers, pharmacists, neuroscientists, and other healthcare professionals involved in advancing the understanding and treatment of psychiatric and neurological disorders.